BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2733245
Number of visits today
428
Number of downloads
2004220
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Ngai D, Mohabeer AL, Mao A, Lino M, Bendeck MP. Stiffness-Responsive Feedback Autoregulation of DDR1 Expression is Mediated by a DDR1-YAP/TAZ Axis. Matrix Biol 2022:S0945-053X(22)00070-1. [PMID: 35562016 DOI: 10.1016/j.matbio.2022.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Wang J, Liu Y, Xie SA, Zhang J, Zhao C, Zhou Y, Pang W, Yao W, Peng Q, Wang X, Zhou J. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening. Circ Res 2023;132:87-105. [PMID: 36475898 DOI: 10.1161/CIRCRESAHA.122.322113] [Reference Citation Analysis]
2 Tian Y, Bai F, Zhang D. New target DDR1: A "double-edged sword" in solid tumors. Biochim Biophys Acta Rev Cancer 2022;1878:188829. [PMID: 36356724 DOI: 10.1016/j.bbcan.2022.188829] [Reference Citation Analysis]
3 Borza CM, Bolas G, Pozzi A. Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease. Front Pharmacol 2022;13:1001122. [DOI: 10.3389/fphar.2022.1001122] [Reference Citation Analysis]
4 Sirvent A, Espie K, Papadopoulou E, Naim D, Roche S. New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance. Front Oncol 2022;12:956926. [DOI: 10.3389/fonc.2022.956926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345